Viehbacher, “Biogen”) announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as treatment for early AD (mild cognitive impairment due to ...

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...

At this time, I'd like to welcome everyone to the Biogen fourth-quarter and full-year 2024 earnings call and business update. [Operator instructions] Today's conference is being recorded. Thank you. I ...

About Eisai Co., Ltd. Eisai's Corporate Concept is "to give ... media channels are intended for audiences outside of the UK and Europe. For audiences based in the UK and Europe, please visit ...

Eisai Co., Ltd.), and connect with us on X , LinkedIn and Facebook . The website and social media channels are intended for audiences outside of the UK and Europe. For audiences based in the UK ...

Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ETCompany ParticipantsTim Power - Head of IRChris Viehbacher ...

(RTTNews) - Biogen Inc. (BIIB), a biotechnology company and Eisai Co., Ltd. On Friday provided an ... options for Alzheimer's patients in Europe. Cash Position: As of September 30, 2024, Biogen ...

IV Maintenance Dosing for the treatment of Early Alzheimer's Disease Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease ...

Jan. 26, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters ... channels are intended for audiences outside of the UK and Europe. For audiences based in the UK and Europe, please visit ...

Europe to review safety data for Eisai-Biogen Alzheimer's drug January 31, 2025 Upon returning to office, U.S. President Donald Trump has launched numerous tariff threats. They range from broad ...

Jan. 31, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters ... Ampace Launches State-of-the-Art Portable Power Stations in Europe Ampace, a leading provider of advanced lithium-ion battery ...